Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Sarasota, FL, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Medical Device Coatings Market (Hydrophilic Coatings, Anti-Microbial Coatings,...
-
Ocean View, Delaware, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Biosensors Market size is estimated to reach USD 29.6 billion by 2024; as per a new research report by Global Market Insights, Inc. ...
-
Kamada and Kedrion, collaborators on development and commercialization of post-exposure treatment for suspected rabies, announced today the filing of a BLA with the FDAOn approval by FDA, the...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate...
-
CRANBURY, N.J., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that 7 posters...
-
WASHINGTON, DC, Aug. 30, 2016 (GLOBE NEWSWIRE) -- The Association of Academic Health Centers (AAHC) is pleased to announce that the first program of its groundbreaking Thought Leadership Institute,...
-
REDWOOD CITY, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that the Phase 4 TOURMALINE study, which compared the efficacy and...
-
SALT LAKE CITY, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 2016...
-
ENOLA, Pa., Aug. 30, 2016 (GLOBE NEWSWIRE) -- This year's National Sexual Assault Conference (NSAC) will be held in Washington, D.C. from August 31 to September 2, focusing on the theme "Hopeful...
-
NEWTON, Mass., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced it will provide an overview of top-line...